Boutique webinar:
Multi-Omic Breakthroughs: Immune Monitoring for Precision Disease Detection
Introducing new approaches to immune monitoring
Helen McGuire, PhD, talks about how her team introduced a cutting-edge approach to immune monitoring that simplifies sample collection in multi-site clinical trials, particularly benefiting remote and underrepresented populations.
- Lung cancer immunotherapy response: A novel immune signature of lung cancer nonresponsiveness, developed using a 50-plus-marker CyTOF™ panel, can predict failure to respond to checkpoint therapies, offering a powerful tool for treatment decisions
- Plasma proteome analysis for disease detection: The SomaScan™ platform, which assesses over 11,000 proteins, is used to track disease progression and immune response in real time, opening up new possibilities for biomarker discovery
- Multi-omic data integration for enhanced predictability: Combining cellular and plasma-based immune data through advanced multi-omic integration can improve clinical outcome prediction
Watch to learn how you can apply these techniques to your own clinical trials and gain insights on how to improve disease detection, treatment effectiveness and overall trial outcomes.
Helen McGuire, PhD
Helen McGuire is a Senior Lecturer at the University of Sydney. Her interests are in emphasizing the use of technology to understand the role of the immune system in clinical applications of human disease. Following studies at UNSW and the Garvan Institute of Medical Research in Sydney, on an NHMRC ECR fellowship she undertook her postdoctoral training at Stanford University, and has subsequently pioneered the introduction of mass cytometry into the wider Australian research landscape.
Boutique webinar:
Multi-Omic Breakthroughs: Immune Monitoring for Precision Disease Detection
A presentation by Helen McGuire, PhD
More webinars
WebinarRethinking Neurodegeneration Through Blood-Based Biomarkers
Proteomics is reshaping how we predict, diagnose, and understand neurodegenerative diseases. In this roundtable, leading experts Tony Wyss-Coray, PhD, and Jacob Vogel, PhD, explore the power of blood-based biomarkers, from deep molecular studies to global-scale datasets using the SomaScan™ Assay. They discuss how protein signatures can reveal brain aging, predict dementia, and track changes in disease pathways over time, with moderation by Steve Williams, MD, PhD. Learn how cutting-edge proteomics is redefining what is possible in neurological research.
WebinarProteomics in Clinical Trials: Lessons from Semaglutide Treatment in Individuals with Obesity
Advancements in proteomic profiling have opened new avenues for understanding the complex mechanisms underlying obesity and its comorbidities. By measuring thousands of proteins at once, researchers gain a comprehensive view of an individual’s metabolic health, revealing subclinical processes and pinpointing potential therapeutic targets.
WebinarPathways to Digital Health: AI and Omics in Rheumatoid Arthritis
Explore how groundbreaking proteomic research is transforming our understanding of rheumatoid arthritis (RA). In this on-demand webinar, Allan Stensballe, PhD, shares new insights into the molecular landscape of RA-affected synovial tissue, revealing how autoantibodies and protein signatures may hold the key to more precise personalized therapies.